Our best ideas to bring innovative treatments to all Americans at a price they can afford
Prescription Drugs
All Prescription Drugs
Congress should strengthen the program to deliver lower drug costs to seniors and taxpayers
The Inflation Reduction Act’s focus on high-grossing drugs leaves savings on the table
Prices negotiated on the program’s first 10 drugs produced significant Medicare savings with little impact on future drug development.
On nearly every measure, startup companies punch above their weight in bringing life-changing drugs to market.
By using a flawed measure of prescription drug costs, CMS failed to tackle high-priced medicines.
Not all R&D spending by the pharmaceutical industry is equally productive. Small companies develop most new medicines.
The FDA should approve more drugs faster, but we should stop forcing Medicare to pay for cost-ineffective drugs.